Contrasting Nymox Pharmaceutical

Contrasting Nymox Pharmaceutical


Nymox Pharmaceutical and Myriad Genetics are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, institutional ownership and analyst recommendations. This is a breakdown of current ratings and price targets for Nymox Pharmaceutical and Myriad Genetics, as provided by MarketBeat.com.



from Biotech News